Skip to main content
SpringerLink
Log in

Preoperative Evaluation and Preparation for Lung Transplantation

  • Chapter
  • First Online:
Anesthesia and Perioperative Care for Organ Transplantation

Abstract

Preoperative evaluation and preparation of lung transplant recipients require a team-based multidisciplinary approach with transplant pulmonologists providing the action plan. With this approach, lung transplant recipients are well prepared before the surgery, improving the opportunities and potentially the outcome of patients with end-stage lung disease. Management of acutely ill lung recipients is evolving with newer approaches, such as “awake” extracorporeal membrane oxygenation and lung assist devices, holding promise for the future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hardy JD, Webb WR, Dalton Jr ML, Walker Jr GR. Lung homotransplantation in man. JAMA. 1963;186:1065–74.

    Article  CAS  PubMed  Google Scholar 

  2. Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med. 1986;314:1140–5.

    Article  Google Scholar 

  3. Cooper JD, Patterson GA, Grossman R, Maurer J. Double-lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis. 1989;139:303–7.

    Article  CAS  PubMed  Google Scholar 

  4. Yusen RD, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report–2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33:1009–24.

    Google Scholar 

  5. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21:297–310.

    Article  PubMed  Google Scholar 

  6. Grannas G, Neipp M, Hoeper MM, et al. Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases. Transplantation. 2008;85:524–31.

    Article  PubMed  Google Scholar 

  7. Euvrard S, Morelon E, Rostaing L, et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med. 2012;367:329–39.

    Article  CAS  PubMed  Google Scholar 

  8. Evon DM, Burker EJ, Sedway JA, Cicale R, Davis K, Egan T. Tobacco and alcohol use in lung transplant candidates and recipients. Clin Transplant. 2005;19:207–14.

    Article  PubMed  Google Scholar 

  9. Kilic A, Merlo CA, Conte JV, Shah AS. Lung transplantation in patients 70 years old or older: have outcomes changed after implementation of the lung allocation score? J Thorac Cardiovasc Surg. 2012;144:1133–8.

    Article  PubMed  Google Scholar 

  10. Jones RM, Enfield KB, Mehrad B, Keeley EC. Prevalence of obstructive coronary artery disease in patients undergoing lung transplantation: case series and review of the literature. Catheter Cardiovasc Interv. 2014;84:1–6.

    Article  PubMed  Google Scholar 

  11. Zanotti G, Hartwig MG, Castleberry AW, et al. Preoperative mild-to-moderate coronary artery disease does not affect long-term outcomes of lung transplantation. Transplantation. 2014;97:1079–85.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Castleberry AW, Martin JT, Osho AA, et al. Coronary revascularization in lung transplant recipients with concomitant coronary artery disease. Am J Transplant. 2013;13:2978–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lederer DJ, Wilt JS, D'Ovidio F, et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med. 2009;180:887–95.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Culver DA, Mazzone PJ, Khandwala F, et al. Discordant utility of ideal body weight and body mass index as predictors of mortality in lung transplant recipients. J Heart Lung Transplant. 2005;24:137–44.

    Article  PubMed  Google Scholar 

  15. Vermeijden JW, Zijlstra JG, Erasmus ME, van der Bij W, Verschuuren EA. Lung transplantation for ventilator-dependent respiratory failure. J Heart Lung Transplant. 2009;28:347–51.

    Article  PubMed  Google Scholar 

  16. Detterbeck FC, Egan TM, Mill MR. Lung transplantation after previous thoracic surgical procedures. Ann Thorac Surg. 1995;60:139–43.

    Article  CAS  PubMed  Google Scholar 

  17. Bertani A, Grossi P, Vitulo P, et al. Successful lung transplantation in an HIV- and HBV-positive patient with cystic fibrosis. Am J Transplant. 2009;9:2190–6.

    Article  CAS  PubMed  Google Scholar 

  18. Sahi H, Zein NN, Mehta AC, Blazey HC, Meyer KH, Budev M. Outcomes after lung transplantation in patients with chronic hepatitis C virus infection. J Heart Lung Transplant. 2007;26:466–71.

    Article  PubMed  Google Scholar 

  19. Helmi M, Love RB, Welter D, Cornwell RD, Meyer KC. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest. 2003;123:800–8.

    Article  PubMed  Google Scholar 

  20. Chalermskulrat W, Sood N, Neuringer IP, et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax. 2006;61:507–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med. 1999;160:1611–6.

    Article  CAS  PubMed  Google Scholar 

  22. Hadjiliadis D, Steele MP, Chaparro C, et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant. 2007;26:834–8.

    Article  PubMed  Google Scholar 

  23. Aris RM, Routh JC, LiPuma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med. 2001;164:2102–6.

    Article  CAS  PubMed  Google Scholar 

  24. De Soyza A, Meachery G, Hester KL, et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. J Heart Lung Transplant. 2010;29:1395–404.

    Article  PubMed  Google Scholar 

  25. Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant. 2006;6:1212–27.

    Article  CAS  PubMed  Google Scholar 

  26. Iribarne A, Russo MJ, Davies RR, et al. Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest. 2009;135:923–8.

    Article  PubMed  Google Scholar 

  27. Low DE, Trulock EP, Kaiser LR, et al. Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema. J Thorac Cardiovasc Surg. 1992;103:1119–26.

    CAS  PubMed  Google Scholar 

  28. Schulman LL, O'Hair DP, Cantu E, McGregor C, Ginsberg ME. Salvage by volume reduction of chronic allograft rejection in emphysema. J Heart Lung Transplant. 1999;18:107–12.

    Article  CAS  PubMed  Google Scholar 

  29. Hadjiliadis D, Chaparro C, Gutierrez C, et al. Impact of lung transplant operation on bronchiolitis obliterans syndrome in patients with chronic obstructive pulmonary disease. Am J Transplant. 2006;6:183–9.

    Article  CAS  PubMed  Google Scholar 

  30. Thabut G, Christie JD, Ravaud P, et al. Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis. Ann Intern Med. 2009;151:767–74.

    Article  PubMed  Google Scholar 

  31. Zeevi A, Lunz J, Feingold B, et al. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant. 2013;32:98–105.

    Article  PubMed  Google Scholar 

  32. Swarup R, Allenspach LL, Nemeh HW, Stagner LD, Betensley AD. Timing of basiliximab induction and development of acute rejection in lung transplant patients. J Heart Lung Transplant. 2011;30:1228–35.

    Article  PubMed  Google Scholar 

  33. Flynn JM, Byrd JC. Campath-1H monoclonal antibody therapy. Curr Opin Oncol. 2000;12:574–81.

    Article  CAS  PubMed  Google Scholar 

  34. Shyu S, Dew MA, Pilewski JM, et al. Five-year outcomes with alemtuzumab induction after lung transplantation. J Heart Lung Transplant. 2011;30:743–54.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Morris PJ, Russell NK. Alemtuzumab (Campath-1H): a systematic review in organ transplantation. Transplantation. 2006;81:1361–7.

    Article  PubMed  Google Scholar 

  36. Peleg AY, Husain S, Kwak EJ, et al. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis. 2007;44:204–12.

    Article  CAS  PubMed  Google Scholar 

  37. Merion RM, Howell T, Bromberg JS. Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin. Transplantation. 1998;65:1481–9.

    Article  CAS  PubMed  Google Scholar 

  38. Ius F, Kuehn C, Tudorache I, et al. Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012;144:1510–6.

    Article  PubMed  Google Scholar 

  39. Toyoda Y, Bhama JK, Shigemura N, et al. Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation. J Thorac Cardiovasc Surg. 2013;145:1065–70. discussion 70-1.

    Article  PubMed  Google Scholar 

  40. Bermudez CA, Rocha RV, Zaldonis D, et al. Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes. Ann Thorac Surg. 2011;92:1226–31. discussion 31-2.

    Article  PubMed  Google Scholar 

  41. Hayanga AJ, Aboagye J, Esper S, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: an evolving strategy in the management of rapidly advancing pulmonary disease. J Thorac Cardiovasc Surg. 2015;149:291–6.

    Article  PubMed  Google Scholar 

  42. Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J Thorac Cardiovasc Surg. 2010;139:765–73. e1.

    Article  PubMed  Google Scholar 

  43. Nosotti M, Rosso L, Tosi D, et al. Extracorporeal membrane oxygenation with spontaneous breathing as a bridge to lung transplantation. Interact Cardiovasc Thorac Surg. 2013;16:55–9.

    Article  PubMed  Google Scholar 

  44. Fuehner T, Kuehn C, Hadem J, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med. 2012;185:763–8.

    Article  PubMed  Google Scholar 

  45. Fischer S, Simon AR, Welte T, et al. Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg. 2006;131:719–23.

    Article  PubMed  Google Scholar 

  46. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update – a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25:745–55.

    Article  PubMed  Google Scholar 

  47. Orens JB, Garrity Jr ER. General overview of lung transplantation and review of organ allocation. Proc Am Thorac Soc. 2009;6:13–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, NW628 MUH, 3459 Fifth Ave., Pittsburgh, PA, 15213, USA

    Matthew R. Morrell M.D. & Joseph M. Pilewski M.D.

Authors
  1. Matthew R. Morrell M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph M. Pilewski M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph M. Pilewski M.D. .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    Kathirvel Subramaniam

  2. Department of Anesthesiology The Clinical and Translational Science Institute The McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Tetsuro Sakai

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this chapter

Cite this chapter

Morrell, M.R., Pilewski, J.M. (2017). Preoperative Evaluation and Preparation for Lung Transplantation. In: Subramaniam, K., Sakai, T. (eds) Anesthesia and Perioperative Care for Organ Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6377-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6377-5_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6375-1

  • Online ISBN: 978-1-4939-6377-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation